Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.135 AUD
Market Cap: 18.2m AUD
Have any thoughts about
Star Combo Pharma Ltd?
Write Note
Section:
 

Relative Value

S66 doesn't have a meaningful market cap.

The Relative Value of one S66 stock under the Base Case scenario is 0.124 AUD. Compared to the current market price of 0.135 AUD, Star Combo Pharma Ltd is Overvalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

S66 Relative Value
Base Case
0.124 AUD
Overvaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
73
vs Industry
65
Median 3Y
0.8
Median 5Y
1
Industry
1
More Details
24.4
P/E
P/E
Price to Earnings
24.4
vs History
15
vs Industry
16
Median 3Y
-3.2
Median 5Y
-4
Industry
16.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
43
Median 3Y
8.3
Median 5Y
7.9
Industry
11.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
29
Median 3Y
-4.4
Median 5Y
-5.8
Industry
17.6
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
71
vs Industry
79
Median 3Y
0.6
Median 5Y
0.8
Industry
1.6
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
58
vs Industry
78
Median 3Y
0.6
Median 5Y
0.7
Industry
1.2
More Details
2.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.5
vs History
60
vs Industry
69
Median 3Y
2.6
Median 5Y
3.1
Industry
3.8
More Details
12.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.5
vs History
14
vs Industry
48
Median 3Y
10.8
Median 5Y
-1.3
Industry
10.3
More Details
12.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.5
vs History
14
vs Industry
52
Median 3Y
10.8
Median 5Y
-1.3
Industry
12.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
52
Median 3Y
5.5
Median 5Y
5
Industry
12.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
30
Median 3Y
-3.2
Median 5Y
-4.2
Industry
15.3
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
66
vs Industry
81
Median 3Y
0.5
Median 5Y
0.6
Industry
1.2
More Details

Multiples Across Competitors

S66 Competitors Multiples
Star Combo Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Star Combo Pharma Ltd
ASX:S66
18.2m AUD 0.7 24.4 12.5 12.5
FR
L'Oreal SA
PAR:OR
181.7B EUR 4.3 28 18.7 22.2
UK
Unilever PLC
LSE:ULVR
114.1B GBP 2.3 20.8 177.8 204.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.8 53.1 36.5 39.8
UK
HALEON PLC
LSE:HLN
34.9B GBP 3.1 28.9 17.2 19.7
DE
Beiersdorf AG
XETRA:BEI
27.8B EUR 2.9 37.6 16 22.9
US
Estee Lauder Companies Inc
NYSE:EL
27B USD 1.7 132.8 13.1 19.9
JP
Kao Corp
TSE:4452
3T JPY 1.9 36 14.3 25.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7.9 -297.8 35.4 37.8
IN
Dabur India Ltd
NSE:DABUR
903.7B INR 7.3 50.5 38.3 46.7
US
Bellring Brands Inc
NYSE:BRBR
9.9B USD 4.9 40.1 25.1 27.4
P/E Multiple
Earnings Growth P/E to Growth
AU
Star Combo Pharma Ltd
ASX:S66
Average P/E: 45.2
24.4
N/A N/A
FR
L'Oreal SA
PAR:OR
28
30%
0.9
UK
Unilever PLC
LSE:ULVR
20.8
25%
0.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
53.1
32%
1.6
UK
HALEON PLC
LSE:HLN
28.9
-7%
N/A
DE
Beiersdorf AG
XETRA:BEI
37.6
61%
0.6
US
Estee Lauder Companies Inc
NYSE:EL
132.8
245%
0.5
JP
Kao Corp
TSE:4452
36
205%
0.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -297.8 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
50.5
39%
1.3
US
Bellring Brands Inc
NYSE:BRBR
40.1
56%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Star Combo Pharma Ltd
ASX:S66
Average EV/EBITDA: 36.8
12.5
N/A N/A
FR
L'Oreal SA
PAR:OR
18.7
28%
0.7
UK
Unilever PLC
LSE:ULVR
177.8
20%
8.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.5
29%
1.2
UK
HALEON PLC
LSE:HLN
17.2
13%
1.3
DE
Beiersdorf AG
XETRA:BEI
16
11%
1.4
US
Estee Lauder Companies Inc
NYSE:EL
13.1
26%
0.5
JP
Kao Corp
TSE:4452
14.3
55%
0.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
35.4
41%
0.9
IN
Dabur India Ltd
NSE:DABUR
38.3
35%
1.1
US
Bellring Brands Inc
NYSE:BRBR
25.1
47%
0.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Star Combo Pharma Ltd
ASX:S66
Average EV/EBIT: 43.6
12.5
N/A N/A
FR
L'Oreal SA
PAR:OR
22.2
34%
0.7
UK
Unilever PLC
LSE:ULVR
204.4
22%
9.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.8
31%
1.3
UK
HALEON PLC
LSE:HLN
19.7
13%
1.5
DE
Beiersdorf AG
XETRA:BEI
22.9
21%
1.1
US
Estee Lauder Companies Inc
NYSE:EL
19.9
35%
0.6
JP
Kao Corp
TSE:4452
25.8
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
37.8
44%
0.9
IN
Dabur India Ltd
NSE:DABUR
46.7
37%
1.3
US
Bellring Brands Inc
NYSE:BRBR
27.4
48%
0.6

See Also

Summary
S66 intrinsic value, competitors valuation, and company profile.
DCF Valuation
S66 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
S66 stock valuation using valuation multiples.
Wall Street Estimates
S66 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
S66 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.